Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06631924 · ClinicalTrials.gov registry record
Intramedullary Fixation for Metacarpal Fractures: A Prospective Study Comparing Outcomes
A clinical trial, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 40
- Enrollment target
NCT06631924: Completed study, sponsored by University of Colorado, Denver.
NCT06631924 is a clinical trial that has completed, run by University of Colorado, Denver. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06631924 has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 40 participants
- Enrollment target
Study Summary
To prove that use of intramedullary cannulated headless hardware fixation of metacarpal fractures provides anatomic reduction, stable fixation, less operative trauma and early, active post-operative mobilization. The study compares two types of implant to determine efficacy in reduction and maintenance of reduction for fracture healing.
Primary Outcome
Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH) outcome measure score.
Interventions
- DEVICE Implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2020-04-23 |
| Est. Completion | 2024-04-16 |
What the finished NCT06631924 record still lists
NCT06631924 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Implant is the first listed.
NCT06631924 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06631924 about?
NCT06631924 is a clinical study titled "Intramedullary Fixation for Metacarpal Fractures: A Prospective Study Comparing Outcomes". To prove that use of intramedullary cannulated headless hardware fixation of metacarpal fractures provides anatomic reduction, stable fixation, less operative trauma and early, active post-operative mobilization. The study compares two types of implant to determine efficacy in reduction and maintena...
What is the current status of trial NCT06631924?
This trial is currently completed. The enrollment target is 40 participants. The study started on 2020-04-23. Estimated completion is 2024-04-16.
What interventions are being tested in trial NCT06631924?
The interventions under investigation include: Implant (DEVICE).
Who is sponsoring clinical trial NCT06631924?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI